Lovelace Biomedical Urged to Probe Studies Using Monkeys From Filthy Lab After PETA Exposé

For Immediate Release:
April 17, 2026

Contact:
Brandi Pharris 202-483-7382

Albuquerque, N.M.

In a letter sent yesterday, PETA urges Lovelace Biomedical to review all experiments on monkeys purchased from the University of Louisiana’s New Iberia Research Center (NIRC), the nation’s largest primate laboratory with 12,000 monkeys.

Last month, PETA released a whistleblower video showing monkeys at NIRC confined in accumulated waste with visible signs of stress and injury. Now, PETA has obtained public records involving NIRC and its pharmaceutical industry clients that raise serious concerns about the health of the monkeys it supplies, including evidence that at least one major drug company, Pfizer, accepted monkeys with known health problems, underscoring a willingness to use sick animals in experiments, which can taint data.

These records show that monkeys were selected for experiments based on age, weight, sex, and availability, not health. Even animals with infections, injuries, and active lesions were not excluded. Some were still sent to a contract laboratory for use in experiments. PETA is concerned this may reflect broader industry practices.

The whistleblower video shows the conditions behind those records, including monkeys stacked in barren cages in small, windowless rooms. Many have extensive hair loss, a well-documented indicator of chronic stress. The footage and records tell the same story: compromised animals are used in experiments.

“Sick monkeys don’t just suffer, they distort results and mislead decisions about what is safe and effective for patients,” says PETA Chief Science Advisor on Primate Experimentation Dr. Lisa Jones-Engel. “PETA strongly urges Lovelace Biomedical to examine its relationship with NIRC, where monkeys are confined in conditions that drive disease and distress and where even compromised animals can still end up in experiments.

In addition to its relationships with Lovelace Biomedical and Pfizer, NIRC sells monkeys to or receives funding to conduct monkey experiments from Charles River Laboratories; Crown Bioscience; CyanVac LLC; Elicio Therapeutics; Gates Foundation; Novavax; Ragon Institute—affiliated with Mass General Brigham, Massachusetts Institute of Technology and Harvard University—Sanofi; SeromYx Systems, Inc.; University of Nebraska Medical Center, among others.

Whistleblower footage inside New Iberia Research Center, released by PETA, shows monkeys confined to cramped, barren steel cages in a windowless room, above filth and pools of standing water—promoting disease spread and endangering animals and staff. An unknown liquid, possibly urine, pools beneath cages suspended from the walls in the squalid rooms. Basic sanitation appears to have broken down.

Federal inspectors have cited NIRC for violating the Animal Welfare Act following the deaths of infant monkeys from dehydration, a monkey who was electrocuted, and for broken or dilapidated cages that contribute to repeated escapes. The U.S. Department of Agriculture recently cited the university when 19 monkeys died after being confined outside, unprotected, in sub-freezing weather. Authorities have imposed substantial fines of more than $158,000.

PETA—whose motto reads, in part, that “animals are not ours to experiment on”—points out that Every Animal Is Someone and offers free Empathy Kits for people who need a lesson in kindness. For more information, please visit PETA.org or follow PETA on XFacebook, or Instagram.

JOIN US
Get urgent alerts, breaking animals rights news, and easy ways to take action for animals!
PETA bunny
This field is for validation purposes and should be left unchanged.
At least one of the following fields is required.
This field is hidden when viewing the form
This field is hidden when viewing the form
Untitled

Get the Latest Tips—Right in Your Inbox
We’ll e-mail you weekly with the latest in vegan recipes, fashion, and more!

By submitting this form, you’re acknowledging that you have read and agree to our privacy policy and agree to receive e-mails from us.